-
-
-
-
-
-
-
HIMS & Hers completes acquisition of Eucalyptus to enter Japan market
-
-
-
-
-
-
-
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
-
-
-
-
-
-
-
KeyBanc Reiterates Sector Weight Rating on Hims and Hers (HIMS)
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Hims and Hers (HIMS)
-
-
-
-
-
-
-
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
HIMS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
-
-
-
-
-
-
-
Hims & Hers plans 2026 Canada expansion with generic semaglutide launch
-
1,168,545 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

